Showing 1 — 20 of 47
SORT: Best Match Most Recent Oldest
VIEW: Basic | Expanded
  • Letters to the Editor August 01, 2007

    Jim Mintz, PhD; Alex Kopelowicz, MD

    Arch Gen Psychiatry. 2007; 64(8):978-978. doi: 10.1001/archpsyc.64.8.978-a

  • Original Investigation February 19, 2014

    Anton P. Porsteinsson, MD; Lea T. Drye, PhD; Bruce G. Pollock, MD, PhD; D. P. Devanand, MD; Constantine Frangakis, PhD; Zahinoor Ismail, MD; Christopher Marano, MD; Curtis L. Meinert, PhD; Jacobo E. Mintzer, MD, MBA; Cynthia A. Munro, PhD; Gregory Pelton, MD; Peter V. Rabins, MD; Paul B. Rosenberg, MD; Lon S. Schneider, MD; David M. Shade, JD; Daniel Weintraub, MD; Jerome Yesavage, MD; Constantine G. Lyketsos, MD, MHS; for the CitAD Research Group
    TOPICS: alzheimer's disease, citalopram, agitation

    JAMA. 2014; 311(7):682-691. doi: 10.1001/jama.2014.93

    Includes: Multimedia, Supplemental Content
  • Original Investigation December 01, 2013

    Ana S. Iltis, PhD; Sahana Misra, MD; Laura B. Dunn, MD; Gregory K. Brown, PhD; Amy Campbell, JD, MBE; Sarah A. Earll; Anne Glowinski, MD, MPE; Whitney B. Hadley, MA; Ronald Pies, MD; James M. DuBois, PhD, DSc
    TOPICS: mental health, research risks

    JAMA Psychiatry. 2013; 70(12):1363-1371. doi: 10.1001/jamapsychiatry.2013.2105

    Includes: CME